Menu
Fechar
Vull donar

BEGOÑA MARTIN CASTILLO

Metabolisme i Càncer
Personal de suport a la recerca
Firma
BEGOÑA MARTIN-CASTILLO
Posició
Investigadors/es Col·laboradors/es
Publicacions

Publicacions

Cuyàs E, Verdura S, Martin-Castillo B, Alarcón T, Lupu R, Bosch-Barrera J, Menendez JA

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy.

Cancers, 2020, 12, 1757 dx.doi.org/10.3390/cancers12071757

Cuyàs E, Gumuzio J, Verdura S, Brunet J, Bosch-Barrera J, Martin-Castillo B, Alarcón T, Encinar JA, Martin ÁG, Menendez JA

The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.

Aging-Us, 2020, 12, 4794-4814 dx.doi.org/10.18632/aging.102887

Verdura S, Cuyàs E, Cortada E, Brunet J, Lopez-Bonet E, Martin-Castillo B, Bosch-Barrera J, Encinar JA, Menendez JA

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.

Aging-Us, 2020, 12, 8-34 dx.doi.org/10.18632/aging.102646

Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA

Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.

Journal of Clinical Medicine, 2020, 9, 1770 dx.doi.org/10.3390/jcm9061770

Cuyàs E, Gumuzio J, Lozano-Sánchez J, Segura-Carretero A, Verdura S, Bosch-Barrera J, Martin-Castillo B, Nonell-Canals A, Llebaria A, Cabello S, Serra C, Sanchez-Martinez M, Martin ÁG, Menendez JA

Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity.

Aging-Us, 2020, 12, 21057-21075 dx.doi.org/10.18632/aging.202154

Lopez-Bonet E, Buxó M, Cuyàs E, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Oliveras G, Meléndez C, Castillo L, Verdura S, Brunet J, Joven J, Garcia M, Saidani S, Martin-Castillo B, Menendez JA

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.

Journal of Clinical Medicine, 2019, 8 dx.doi.org/10.3390/jcm8122180

Menendez JA, Cuyàs E, Folguera-Blasco N, Verdura S, Martin-Castillo B, Joven J, Alarcón T

In silico clinical trials for anti-aging therapies.

Aging-Us, 2019, 11, 6591-6601 dx.doi.org/10.18632/aging.102180

Verdura S, Cuyàs E, Martin-Castillo B, Menendez JA

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy.

OncoImmunology, 2019, 8, e1633235 dx.doi.org/10.1080/2162402X.2019.1633235

Cuyàs E, Fernández-Arroyo S, Buxó M, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Verdura S, Brunet J, López-Bonet E, Garcia M, Saidani S, Joven J, Martin-Castillo B, Menendez JA

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.

Aging-Us, 2019, 11, 2874-2888 dx.doi.org/10.18632/aging.101960

Cuyàs E, Buxó M, Ferri Iglesias MJ, Verdura S, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Joven J, Brunet J, López-Bonet E, Garcia M, Saidani S, Queralt Moles X, Martin-Castillo B, Menendez JA

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.

Frontiers in oncology, 2019, 9, 193-193 dx.doi.org/10.3389/fonc.2019.00193

Formulari de contacte

Coneix l’IDIBGI!

 menu